Closes $4M Series B Funding

Carmell Therapeutics closes $4M Series B round of funding

PITTSBURGH, July 11, 2017 /PRNewswire/ — Carmell Therapeutics, a biotechnology company focused on developing and commercializing regenerative medicine technologies, announced today that on June…